Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia. (Q44023168)

From Wikidata

Revision as of 12:30, 11 August 2019 by Daniel Mietchen (talk | contribs) (‎Created claim: main subject (P921): leukemia (Q29496), batch #17153)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

title

Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

main subject

lymphocyte

0 references

leukemia

0 references

author name string

K C Doney

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

T Chauncey

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

F R Appelbaum

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

Seattle Bone Marrow Transplant Team

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

published in

Bone Marrow Transplantation

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

volume

29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

page(s)

817-823

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

cites work

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Rituximab dose-escalation trial in chronic lymphocytic leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703548

retrieved

21 January 2018

Identifiers

DOI

10.1038/SJ.BMT.1703548

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

PubMed publication ID

12058231

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12058231

retrieved

29 November 2017

 

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44023168&oldid=994930566"